Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization.

Both insulin and IGF-1 have been implicated in control of retinal endothelial cell growth, neovascularization, and diabetic retinopathy. To precisely define the role of insulin and IGF-1 signaling in endothelium in these processes, we have used the oxygen-induced retinopathy model to study mice with a vascular endothelial cell-specific knockout of the insulin receptor (VENIRKO) or IGF-1 receptor (VENIFARKO). Following relative hypoxia, VENIRKO mice show a 57% decrease in retinal neovascularization as compared with controls. This is associated with a blunted rise in VEGF, eNOS, and endothelin-1. By contrast, VENIFARKO mice show only a 34% reduction in neovascularization and a very modest reduction in mediator generation. These data indicate that both insulin and IGF-1 signaling in endothelium play a role in retinal neovascularization through the expression of vascular mediators, with the effect of insulin being most important in this process.

[1]  C. Kahn,et al.  The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. , 2003, The Journal of clinical investigation.

[2]  D. Pinsky,et al.  Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction , 2002, Current opinion in critical care.

[3]  G. Yancopoulos,et al.  Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. , 2002, The Journal of clinical investigation.

[4]  T. Hamanaka,et al.  Retinal ischemia and angle neovascularization in proliferative diabetic retinopathy. , 2001, American journal of ophthalmology.

[5]  J. Chiu,et al.  Endothelial exposure to hypoxia induces Egr‐1 expression involving PKCα‐mediated Ras/Raf‐1/ERK1/2 pathway , 2001, Journal of cellular physiology.

[6]  R. Higgins,et al.  Captopril improves retinal neovascularization via endothelin-1. , 2001, Investigative Ophthalmology and Visual Science.

[7]  R K Jain,et al.  Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Taraboletti,et al.  Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 2000, The American journal of pathology.

[9]  N. Vaziri,et al.  Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. , 2000, American journal of physiology. Endocrinology and metabolism.

[10]  M. Shichiri,et al.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. , 2000, Diabetes care.

[11]  G. Semenza HIF-1: mediator of physiological and pathophysiological responses to hypoxia. , 2000, Journal of applied physiology.

[12]  G. King,et al.  Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. , 2000, Circulation.

[13]  P. Campochiaro,et al.  Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. , 2000, The American journal of pathology.

[14]  A. Zeiher,et al.  Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Lois E. H. Smith,et al.  Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor , 1999, Nature Medicine.

[16]  A. Adamis,et al.  Insulin-induced vascular endothelial growth factor expression in retina. , 1999, Investigative ophthalmology & visual science.

[17]  T. Fujimori,et al.  Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR. , 1999, Hypertension.

[18]  Alan W. Stitt,et al.  Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. , 1999, Biochemical and biophysical research communications.

[19]  M. Quon,et al.  Insulin stimulates both endothelin and nitric oxide activity in the human forearm. , 1999, Circulation.

[20]  D. Silver,et al.  Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.

[21]  Y. Zou,et al.  Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.

[22]  J. Cunha-Vaz Lowering the risk of visual impairment and blindness , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[23]  G. King,et al.  Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.

[24]  A. Akaike,et al.  Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina. , 1998, European journal of pharmacology.

[25]  J. Stone,et al.  Mechanisms of retinal angiogenesis , 1997, Progress in Retinal and Eye Research.

[26]  L. Aiello,et al.  Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. , 1997, Diabetes/metabolism reviews.

[27]  L. Groop,et al.  The Effect of Glycaemic Control and the Introduction of Insulin Therapy on Retinopathy in Non‐insulin‐dependent Diabetes Mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[28]  G. Desideri,et al.  Effect of ACE Inhibition on Spontaneous and Insulin-Stimulated Endothelin-1 Secretion: In Vitro and In Vivo Studies , 1997, Diabetes.

[29]  G. Katzman Retinopathy of prematurity: is suppression of neovascularization achievable? , 1996, Jornal de Pediatria.

[30]  G. King,et al.  Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. , 1996, Investigative ophthalmology & visual science.

[31]  G. Lutty,et al.  Localization of vascular endothelial growth factor in human retina and choroid. , 1996, Archives of ophthalmology.

[32]  M. White,et al.  Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase , 1996, Molecular and cellular biology.

[33]  D. S. Mcleod,et al.  Vaso-obliteration in the canine model of oxygen-induced retinopathy. , 1996, Investigative ophthalmology & visual science.

[34]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[35]  J. Blenis,et al.  Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation , 1994, Molecular and cellular biology.

[36]  R. Dash,et al.  Effect of insulin therapy on progression of retinopathy in noninsulin-dependent diabetes mellitus. , 1993, American journal of ophthalmology.

[37]  M. Yacoub,et al.  Antigenic heterogeneity of vascular endothelium. , 1992, The American journal of pathology.

[38]  M. Loeken,et al.  Stimulation of endothelin-1 gene expression by insulin in endothelial cells. , 1991, The Journal of biological chemistry.

[39]  S Moncada,et al.  Role of endothelium-derived nitric oxide in the regulation of blood pressure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Deckert,et al.  Two-Year Experience with Continuous Subcutaneous Insulin Infusion in Relation to Retinopathy and Neuropathy , 1985, Diabetes.

[41]  K. Dahl-Jørgensen,et al.  Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. , 1985, British medical journal.

[42]  P. Huang,et al.  Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. , 2001, Investigative ophthalmology & visual science.

[43]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[44]  A. Dembińska-kieć,et al.  Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells. , 1999, Acta biochimica Polonica.

[45]  R. Klein,et al.  The 14-year incidence of visual loss in a diabetic population. , 1998, Ophthalmology.

[46]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[47]  F. Murad,et al.  The nitric oxide-cyclic GMP signal transduction pathway in vascular smooth muscle preparations and other tissues. , 1992, Japanese journal of pharmacology.